JPRN-UMIN000002392已完成未知
Phase 1/2 study of Multiple-Vaccine with CpG-ODN Therapy in Patient with Refractory Colon Cancer to Chemotherapy. - Phase 1/2 study of Multiple-Vaccine with CpG-ODN Therapy in Patient with Refractory Colon Cancer to Chemotherapy.
Institute of Medical Science, The university of Tokyo.0 个研究点目标入组 25 人开始时间: 2009年8月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Pregnancy 2.Breastfeeding 3.Concurrent treatment with steroids or immunosuppressing agent 4.No other malignancy requiring treatment 5.No severe cardio-vascular disease 6.Decision of unsuitableness by principal investigator or physician-in-charge
研究者
相似试验
招募中
1 期
Phase I study of Multiple-Vaccine Therapy in Patient with Refractory Breast Cancer to Chemotherapy.Breast CancerJPRN-UMIN000002408Department of Breast and Endocrine Surgery, Juntendo University School of Medicine6
已完成
1 期
Phase I study of Multiple-Vaccine Therapy in Patient with Refractory Non-Small-Cell Lung Cancer to Chemotherapy.on-Small-Cell Lung CancerJPRN-UMIN000002141Department of Respiratory Medicine, Juntendo University School of Medicine9
进行中（未招募）
不适用
Phase I/II study of immunization with multiple peptides mixed with the immunological adjuvant CpG 7909 in HLA-A2 patients with metastatic melanoma LUD 03-007 - LUD 03-007HLA-A2 patients with metastatic melanomaEUCTR2004-004686-15-DEudwig Institute For Cancer Research14
已完成
2 期
Randomized Phase 2 With CpG-ODN in Malignant GlioblastomaGlioblastomaNCT00190424Assistance Publique - Hôpitaux de Paris80
已完成
1 期
Study of OTSGC-A24 Vaccine in Advanced Gastric Cancergastric cancerJPRN-jRCT2091220115Wakayama medical university Second department of surgery Hiroki Yamaue23